Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 1398-1405, March 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiGiovanni, J.
Right arrow Articles by Eastin, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DiGiovanni, J.
Right arrow Articles by Eastin, W. C., Jr.

Evidence for a Common Genetic Pathway Controlling Susceptibility to Mouse Skin Tumor Promotion by Diverse Classes of Promoting Agents1

John DiGiovanni2, Susan C. Walker, Linda Beltran, Masashi Naito and William C. Eastin, Jr.

University of Texas M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957 [J. D., S. C. W., L. B., M. N.], and Carcinogenesis and Toxicology Evaluation Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [W. C. E.]

The present study has compared different mouse stocks and strains with known sensitivity to phorbol ester skin tumor promotion for their sensitivities to skin tumor promotion by a prototypic organic peroxide (benzoyl peroxide, BzPo) and anthrone (chrysarobin, Chr) tumor promoter. Following initiation with either 7,12-dimethylbenz(a)anthracene and/or N-methyl-N'-nitro-N-nitrosoguanidine, groups of mice were promoted with several different doses of each promoting agent. Among mice selectively bred for sensitivity to phorbol ester promotion, the order of sensitivity to BzPo was inbred SENCAR (SSIn) > SENCAR > CD-1. With Chr as the promoter, the order of sensitivity was SENCAR > SSIn > CD-1. Concurrent tumor promotion experiments examined the responsiveness of two common inbred mouse strains, DBA/2 and C57BL/6. The phorbol ester-responsive mouse strain, DBA/2, was more sensitive to skin tumor promotion by Chr than was C57BL/6 at all doses tested but was clearly less sensitive than both SENCAR and SSIn mice. Finally, DBA/2 and C57BL/6 mice were similar in their responsiveness to BzPo promotion, but again both of these inbred strains were significantly less sensitive than were SSIn and SENCAR mice to this organic peroxide type of skin tumor promoter. Histological evaluations comparing SENCAR and C57BL/6 mice revealed that a major difference between these strains in response to multiple Chr and BzPo treatments was in the inflammatory response (measured by edema formation). Unlike 12-O-tetradecanoylphorbol-13-acetate, Chr and BzPo did not induce dramatic differences in the epidermal hyperplasia (as measured by epidermal thickness) in these two mouse lines. The results presented in this paper suggest that there is a common pathway controlling susceptibility to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate, BzPo, and chrysarobin. These results are discussed in terms of a possible genetic model(s) for skin tumor promotion in mice.

1 Research supported by USPHS Grant CA 38871.

2 To whom requests for reprints should be addressed, at University of Texas M. D. Anderson Cancer Center, Science Park-Research Division, P.O. Box 389, Smithville, TX 78957.

Received 7/23/90. Accepted 12/18/90.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
L. M. Shantz, Y. Guo, J. A. Sawicki, A. E. Pegg, and T. G. O'Brien
Overexpression of a dominant-negative ornithine decarboxylase in mouse skin: effect on enzyme activity and papilloma formation
Carcinogenesis, April 1, 2002; 23(4): 657 - 664.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. G. Coghlan, I. Gimenez-Conti, H. E. Kleiner, S. M. Fischer, J. E. Rundhaug, C. J. Conti, T. J. Slaga, and J. DiGiovanni
Development and initial characterization of several new inbred strains of SENCAR mice for studies of multistage skin carcinogenesis
Carcinogenesis, April 1, 2000; 21(4): 641 - 646.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.